Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Eduardo A. Padlan
Introduction
Eduardo A. Padlan is a notable inventor based in Kensington, California, recognized for his significant contributions to the field of biotechnology. His work primarily focuses on the development of modified antibodies that have applications in cancer diagnostics and treatment. With one patent to his name, Padlan's innovations are paving the way for advancements in medical science.
Latest Patents
Padlan's patent, titled "Use of modified antibodies with human milk fat globule specificity," describes an analogue peptide that selectively binds to carcinoma antigens. This invention involves substituting amino acids in the variable regions of antibody chains, allowing for enhanced specificity and efficacy in targeting cancer cells. The polypeptide can be used in diagnostic kits for carcinomas, methods for in vivo imaging, and treatments for both primary and metastasized carcinomas. Additionally, it includes methods for purging neoplastic cells from biological fluids, showcasing its potential in both diagnostic and therapeutic applications.
Career Highlights
Padlan's career is marked by his dedication to cancer research, particularly through his work with the Cancer Research Fund. His innovative approach to antibody modification has garnered attention in the scientific community, contributing to the ongoing fight against cancer. His research not only aims to improve diagnostic techniques but also seeks to enhance treatment options for patients suffering from various forms of cancer.
Collaborations
Padlan has collaborated with esteemed colleagues such as Fernando Jose Rebelo Do Couto and Roberto L. Ceriani. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of cancer research.
Conclusion
Eduardo A. Padlan's contributions to biotechnology and cancer research exemplify the impact of innovative thinking in medicine. His patented work on modified antibodies represents a significant step forward in the development of effective cancer diagnostics and treatments. Through his ongoing research and collaborations, Padlan continues to inspire advancements in the fight against cancer.